绿康生化(002868) - 2023 Q1 - 季度财报

Revenue and Profitability - The company's revenue for Q1 2023 reached ¥100,190,694.85, representing a 59.83% increase compared to ¥62,687,107.78 in the same period last year[4] - The total revenue for Q1 2023 was approximately ¥134.54 million, representing a 72.80% increase compared to ¥77.86 million in the same period last year[15] - The net profit attributable to shareholders was -¥10,145,375.67, a decrease of 13.82% from -¥8,913,785.79 year-on-year[4] - The net profit for Q1 2023 was -10,416,863.97 CNY, compared to -9,003,935.49 CNY in Q1 2022, indicating a decline of approximately 15.7% year-over-year[27] - The company's gross profit was ¥-10,976,905.22, reflecting a decrease compared to the previous period's gross profit of ¥-7,675,193.16[25] - The total comprehensive income attributable to the parent company was -10,145,375.67 CNY, compared to -8,913,785.79 CNY in the same quarter last year[28] Cash Flow and Financial Position - Cash flow from operating activities showed a negative net amount of -¥61,917,676.50, a drastic decline from ¥5,001,432.08 in the same quarter last year, indicating a 1,338% decrease[4] - Cash flow from operating activities showed a net outflow of -61,917,676.50 CNY, a significant decrease from a net inflow of 5,001,432.08 CNY in Q1 2022[28] - The company experienced a net cash outflow from financing activities of -93,099,601.21 CNY, compared to a net inflow of 13,425,947.50 CNY in the previous year[29] - Cash and cash equivalents increased to ¥42,933,481.60 from ¥23,760,865.33, marking an increase of about 80.7%[22] - Cash received from tax refunds decreased by 54.12% to ¥10.92 million from ¥23.80 million due to a reduction in VAT refunds[15] - The cash received from bank loans increased by 56.83% to ¥122.43 million, reflecting the renewal of bank loans[15] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥1,176,564,201.90, down 5.11% from ¥1,239,862,406.54 at the end of the previous year[4] - The total assets at the end of the reporting period were ¥1,176,564,201.90, compared to ¥1,239,862,406.54 at the beginning of the year, a decrease of approximately 5.1%[24] - Total liabilities decreased to ¥587,680,408.76 from ¥640,561,749.43, a reduction of approximately 8.2%[24] - The company's equity attributable to shareholders decreased to ¥585,543,513.46 from ¥595,688,889.13, indicating a decline of about 1.9%[24] Inventory and Expenses - The company reported a significant increase in inventory, which rose by 84.53% to ¥164,340,165.06 from ¥89,060,779.22[9] - Total operating costs amounted to ¥111,167,600.07, up from ¥70,362,300.94, indicating an increase of about 58.0%[25] - Research and development expenses were ¥5,610,427.62, slightly down from ¥5,785,241.05, showing a decrease of about 3.0%[25] - The company experienced a 249.16% increase in financial expenses, amounting to ¥6,727,702.05, attributed to higher financing costs[12] - Cash paid for purchasing goods and services surged by 187.56% to ¥172.11 million, primarily due to the addition of the new subsidiary Jiangxi Weike[15] - The cash paid for taxes increased by 362.23% to ¥8.26 million from ¥1.79 million, attributed to tax payments from the new subsidiary Jiangxi Weike[15] Investments and Acquisitions - The investment income surged to ¥20,610,351.67, a 519.07% increase compared to a loss of -¥4,918,160.70 in the previous year, due to the sale of thermal power assets[12] - The company recorded a substantial increase in government subsidies, which rose by 286.74% to ¥4,189,281.45 from ¥1,083,242.05[12] - The company acquired 100% equity of Jiangxi Weike, resulting in cash payments of approximately ¥92.12 million[15] - The company’s goodwill increased to ¥65,966,311.97 following the acquisition of Jiangxi Weike, reflecting a 100% change as it was previously zero[9] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,545, with the largest shareholder holding 30.43% of the shares[17] - The basic and diluted earnings per share for Q1 2023 were both -0.07 CNY, compared to -0.06 CNY in Q1 2022[28] Audit Information - The company did not undergo an audit for the Q1 2023 report[31]